Scala Biodesign

Provider of computational protein design solutions at scale

placeTel Aviv, Tel Aviv, Israel calendar_todayFounded 2021 language scala-bio.com

Social engagement

Social engagement: 6.2K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include TLV Partners, Grove Ventures.

Investor typeCountShare
Venture capital250%
Private equity125%
Other / undisclosed125%

Recent activity

25 Jun 2026
Event
webinar on enzyme design with ScalaOS
21 Jun 2026
Event
Webinar: Design Hard-Working Enzymes Smoothly With ScalaOS Software
8 Jun 2026
Event
ScalaOS software webinar with Adi Goldenzweig
Coming soon